MX2023004137A - Compuestos aromaticos sustituidos y composiciones farmaceuticas de los mismos. - Google Patents

Compuestos aromaticos sustituidos y composiciones farmaceuticas de los mismos.

Info

Publication number
MX2023004137A
MX2023004137A MX2023004137A MX2023004137A MX2023004137A MX 2023004137 A MX2023004137 A MX 2023004137A MX 2023004137 A MX2023004137 A MX 2023004137A MX 2023004137 A MX2023004137 A MX 2023004137A MX 2023004137 A MX2023004137 A MX 2023004137A
Authority
MX
Mexico
Prior art keywords
sub
optionally substituted
pharmaceutical compositions
aromatic compounds
substituted aromatic
Prior art date
Application number
MX2023004137A
Other languages
English (en)
Inventor
Lyne Gagnon
Original Assignee
Pharmaceutique Ingenew Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaceutique Ingenew Inc filed Critical Pharmaceutique Ingenew Inc
Publication of MX2023004137A publication Critical patent/MX2023004137A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/68—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/11—Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/26—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C47/27—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de fórmula I o II, métodos de preparación y de uso de los mismos. La fórmula I tiene un grupo aromático central con sustituyentes como sigue: (ver formula I) en donde G1 es -(CH2)nC(R1)(R2)OH, -(CH2)n-CHO, -(CH2)nC(O)NR1R2, -(CH2)nCH (R1)NR1R2, - (CH2)nC(O)OR3, -(CH2)n-CH(R1)O-R3, o -(CH2)nC(O)R3; G2 y G4 son independientemente H, OH, F, o Cl, donde G2 también puede ser NH2; G3 y G5 son independientemente H, F, Cl, OH, -(CH2)n -heterociclo opcionalmente sustituido, - (CH2)n-fenilo opcionalmente sustituido, -(CH2)nC3H5, alquilo de C1-C6 opcionalmente sustituido, alquenilo de C2-C6 opcionalmente sustituido, -C(O)-R3, o CH(OH)-R3; y G6 es H, F, Cl, OH, -(CH2)n-(heterociclo opcionalmente sustituido), -(CH2)n-(fenilo opcionalmente sustituido), o (CH2)nCOOH, en donde • n es un número entero seleccionado entre 0 y 5, • R1 y R2 se seleccionan independientemente entre H y un grupo alquilo de C1-C6 opcionalmente sustituido, y • R3 es un grupo alquilo de C1-C6 opcionalmente sustituido o cuando está presente en G1 forma una lactona con el grupo aromático central, o una sal farmacéuticamente aceptable del mismo.
MX2023004137A 2020-10-06 2021-10-05 Compuestos aromaticos sustituidos y composiciones farmaceuticas de los mismos. MX2023004137A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063088266P 2020-10-06 2020-10-06
PCT/CA2021/051395 WO2022073115A1 (en) 2020-10-06 2021-10-05 Substituted aromatic compounds and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
MX2023004137A true MX2023004137A (es) 2023-06-22

Family

ID=81127124

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023004137A MX2023004137A (es) 2020-10-06 2021-10-05 Compuestos aromaticos sustituidos y composiciones farmaceuticas de los mismos.

Country Status (10)

Country Link
US (1) US20240043372A1 (es)
EP (1) EP4225724A4 (es)
JP (1) JP2024512510A (es)
KR (1) KR20230104610A (es)
CN (1) CN116568291A (es)
AU (1) AU2021356346A1 (es)
CA (1) CA3195137A1 (es)
IL (1) IL302014A (es)
MX (1) MX2023004137A (es)
WO (1) WO2022073115A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ610851A (en) * 2010-10-27 2015-05-29 Prometic Biosciences Inc Compounds and compositions for the treatment of cancer
TWI689490B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
CN106999458B (zh) * 2014-10-10 2021-04-13 普罗米蒂克医药Smt有限公司 用于预防和治疗糖尿病的经取代芳族化合物和药物组合物
MX2017004733A (es) * 2014-10-10 2017-07-17 Prometic Pharma Smt Ltd Compuestos aromaticos sustituidos y composiciones farmaceuticas para la prevencion y tratamiento de osteoporosis.

Also Published As

Publication number Publication date
US20240043372A1 (en) 2024-02-08
CA3195137A1 (en) 2022-04-14
AU2021356346A1 (en) 2023-06-15
AU2021356346A9 (en) 2024-04-18
EP4225724A1 (en) 2023-08-16
WO2022073115A1 (en) 2022-04-14
JP2024512510A (ja) 2024-03-19
KR20230104610A (ko) 2023-07-10
IL302014A (en) 2023-06-01
CN116568291A (zh) 2023-08-08
EP4225724A4 (en) 2024-10-23

Similar Documents

Publication Publication Date Title
RS53569B1 (en) NEW COMPOUNDS AND COMPOSITIONS, AND PROCEDURES FOR USE
EA201490554A1 (ru) Пирролобензодиазепины
EA200201141A1 (ru) Производные тропана, полезные для терапии
HRP20000182B1 (en) Processes and intermediates for preparing anti-cancer compounds
CR20210050A (es) Agente profiláctico o terapéutico para atrofia muscular espinal
WO2003080580A3 (en) Quinoline derivatives and their use as 5-ht6 ligands
RS51674B (en) PIPERIDIN-4-IL-PIRIDAZIN-3-ILAMINE DERIVATIVES AS A FAST DISSOCATING DOPAMIN 2 RECEIVER ANTAGONISTS
HUP0002209A2 (hu) 4-Szubsztituált-9-dezoxo-9A-aza-9A-homoeritromicin-származékok és e vegyületeket tartalmazó gyógyászati készítmények
ES8204739A1 (es) Un procedimiento para preparar compuestos de cefem
IL96821A (en) 3-aminopiperidine derivatives, related nitrogen containing heterocycles and pharmaceutical compositions containing them
ES410732A1 (es) Procedimiento para la preparacion de derivados olefinicos de piperidino-4-sustituidos.
HRP20020175B1 (en) N-heterocyclikc derivatives as nos inhibitors
RU2010116253A (ru) Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила
RS54717B1 (en) PROSTAGLANDIN NITRO OXIDERIVES
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
AU3415599A (en) Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
SE7602122L (sv) Nya piperazinyliminorifamyciner och sett att framstella desamma
RU2011116164A (ru) Новые производные оксазолидинона с циклическим амидоксимом или циклическим амидразоном и содержащие их фармацевтические композиции
GB1077173A (en) Substituted alkylene piperidines and methods of preparation thereof
MX2023004137A (es) Compuestos aromaticos sustituidos y composiciones farmaceuticas de los mismos.
RU2013100177A (ru) Способ йодирования производных фенола
IE36710L (en) Hydrazinopyridazine derivatives
DE60043293D1 (de) VAKUOLAR-TYP (H+)-ATPase-HEMMENDE VERBINDUNGEN, ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN
MXPA03009158A (es) Azepinas y diazepinas bi y triciclicas substituidas de n-bifenilcarbonil y n-fenilpiridilcarbonil como agonistas de la vasopresion.
GB1315901A (en) Benzothieno 3,3-d- and benzofuro 3,2-d pyrimidines inhibitors of platelet aggregation